Postoperative 5-fluorouracil versus intraoperative mitomycin C in high-risk glaucoma filtering surgery: extended follow up

• Published in: Clinical & experimental ophthalmology Vol. 31; no. 3; pp. 199 - 205
• Main Authors: Akarsu, Cengiz, Önol, Merih, Hasanreisoglu, Berati
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Science Pty 01-06-2003
• Subjects: 5-fluorouracil; Adult; Aged; Female; Filtering Surgery - adverse effects; Fluorouracil - therapeutic use; glaucoma; Glaucoma - surgery; high-risk surgery; Humans; Intraocular Pressure - drug effects; Intraoperative Care; Male; Middle Aged; Mitomycin - therapeutic use; mitomycin C; Preoperative Care; Retrospective Studies; trabeculectomy; Visual Acuity
• ISSN: 1442-6404; 1442-9071
• DOI: 10.1046/j.1442-9071.2003.00645.x

Purpose: To compare the long‐term efficacy and safety of postoperative subconjunctival 5‐fluorouracil (5‐FU) injections with that of intraoperative mitomycin C (MMC) in eyes at high risk for failure of trabeculectomy.
Methods: In a retrospective, non‐randomized comparative trial, 36 eyes of 36 consecutive patients at high risk for failure of trabeculectomy underwent glaucoma filtering surgery with either postoperative subconjunctival 5‐FU injections (19 eyes) or intraoperative application of MMC (17 eyes). Intraocular pressure, number of postoperative antiglaucoma medications, postoperative visual acuity, interventions, and complications were evaluated.
Results: Overall success (intraocular pressure ≤21 mmHg) at 1 year was 73.6% in the 5‐FU group and 82.3% in the MMC group. The cumulative 4‐year success was 52.6% in the 5‐FU group and 60.5% in the MMC group (P = 0.6). At 4‐year follow up, mean ± SD intraocular pressures were 17.58 ± 4.01 mmHg in the 5‐FU group and 13.33 ± 3.36 mmHg in the MMC group (P = 0.01). There was no significant difference in the number of post­operative medications (P = 0.84), appearance of blebs (P = 0.20), final visual acuity (P = 1.00), and complications (P > 0.05) between the groups.
Conclusions: These results suggest that both postoperative 5‐FU injections and intraoperative MMC application have long‐term success in high‐risk patients. However, MMC results in a greater decrease in intraocular pressure than 5‐FU.